|

PEP07 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • PharmaEngine2

Indications

  • Cancer2
  • Lymphoma, Mantle-Cell1
  • Metastatic Solid Tumor1
  • Acute Myeloid Leukemia1
  • Advanced Solid Tumor1

Other2 trials

A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
Phase 1
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.